London 24 May 2019
Beazley plc announces a block listing application has been made for a total of 4,650,000 ordinary shares of five pence each in the capital of the Company to be admitted to the premium listing segment of the Official List of the Financial Conduct Authority and admitted to trading on the main market of London Stock Exchange plc.
4,650,000 ordinary shares of five pence each will be block listed pursuant to the Company's following schemes:
Number of ordinary shares
Beazley plc Save As You Earn Share Option Plan 2016
Beazley plc US Savings related share option plan 2016
Beazley plc Long Term Incentive Plan 2016
Admission is expected to become effective on 31 May 2019.
The shares will be issued fully paid and will rank pari passu in all respects with the existing issued ordinary shares of the Company.
For further information please contact:
+44 (0)20 7674 7758
Note to editors:
Beazley plc (BEZ.L) is the parent company of specialist insurance businesses with operations in Europe, United States, Canada, Latin America and Asia. Beazley manages seven Lloyd's syndicates and, in 2018, underwrote gross premiums worldwide of $2,615.3 million. All Lloyd's syndicates are rated A by A.M. Best.
Beazley's underwriters in the United States focus on writing a range of specialist insurance products. In the admitted market, coverage is provided by Beazley Insurance Company, Inc., an A.M. Best A rated carrier licensed in all 50 states. In the surplus lines market, coverage is provided by the Beazley syndicates at Lloyd's.
Beazley is a market leader in many of its chosen lines, which include professional indemnity, cyber, property, marine, reinsurance, accident and life, and political risks and contingency business.
For more information please go to: www.beazley.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.